| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...733520M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0033520 |
| P953 | full work available at URL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305321 |
| http://dx.plos.org/10.1371/journal.pone.0033520 | ||
| https://europepmc.org/articles/PMC3305321 | ||
| https://europepmc.org/articles/PMC3305321?pdf=render | ||
| https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0033520&type=printable | ||
| P932 | PMC publication ID | 3305321 |
| P698 | PubMed publication ID | 22438942 |
| P5875 | ResearchGate publication ID | 221967838 |
| P2093 | author name string | Jonathan Henriksen | |
| Gregory J. Metzger | |||
| Stephen C. Schmechel | |||
| Anthony E. Rizzardi | |||
| Nikolaus K. Rosener | |||
| Stephen C. Dankbar | |||
| P2860 | cites work | Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer | Q24528253 |
| Gene expression profiling predicts clinical outcome of prostate cancer | Q24594253 | ||
| Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations | Q24607850 | ||
| A method for detecting and correcting feature misidentification on expression microarrays | Q24796720 | ||
| Genome-wide atlas of gene expression in the adult mouse brain | Q26253934 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study. | Q43059250 | ||
| Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk | Q43144476 | ||
| A six-gene signature predicting breast cancer lung metastasis. | Q43729093 | ||
| Cancer risk prediction models: a workshop on development, evaluation, and application | Q44065523 | ||
| Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies | Q46081400 | ||
| A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays | Q46157946 | ||
| Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10. | Q47290089 | ||
| Use of Expression Analysis to Predict Outcome After Radical Prostatectomy | Q47392520 | ||
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer | Q51692190 | ||
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Q51925963 | ||
| Reporting recommendations for tumor marker prognostic studies (REMARK). | Q53268902 | ||
| Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma | Q53290562 | ||
| Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining | Q53664980 | ||
| Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer | Q53851160 | ||
| Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning | Q28215266 | ||
| Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma | Q28290466 | ||
| A pyramid approach to subpixel registration based on intensity | Q29614713 | ||
| Primary histologic diagnosis using automated whole slide imaging: a validation study | Q30477700 | ||
| Isolation of circulating tumor cells using a microvortex-generating herringbone-chip | Q30497257 | ||
| Automated evaluation and normalization of immunohistochemistry on tissue microarrays with a DNA microarray scanner | Q30964502 | ||
| Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma | Q30965944 | ||
| Quantitative methods for genome-scale analysis of in situ hybridization and correlation with microarray data | Q31144743 | ||
| Laser-capture microdissection: opening the microscopic frontier to molecular analysis | Q32050582 | ||
| Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance | Q33252647 | ||
| Laser-capture microdissection in prostate cancer research: establishment and validation of a powerful tool for the assessment of tumour-stroma interactions | Q33314416 | ||
| A relationship between slide quality and image quality in whole slide imaging (WSI) | Q33356967 | ||
| Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue | Q33367977 | ||
| Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy | Q33633919 | ||
| Determination of the Her-2/neu gene amplification status in cytologic breast cancer specimens using automated silver-enhanced in-situ hybridization (SISH). | Q33641172 | ||
| Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer | Q33845160 | ||
| Molecular markers for predicting response to tamoxifen in breast cancer patients | Q34070239 | ||
| Analysis of gene expression in pathophysiological states: balancing false discovery and false negative rates | Q34270996 | ||
| The Monte Carlo method | Q34729293 | ||
| Defining aggressive prostate cancer using a 12-gene model | Q35060298 | ||
| Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy | Q35751889 | ||
| Optimizing molecular signatures for predicting prostate cancer recurrence | Q36182273 | ||
| Use of whole slide imaging in surgical pathology quality assurance: design and pilot validation studies | Q36448585 | ||
| A candidate molecular signature associated with tamoxifen failure in primary breast cancer | Q37038692 | ||
| Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer | Q37038702 | ||
| Cross-hybridization modeling on Affymetrix exon arrays. | Q37090780 | ||
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). | Q37768426 | ||
| Microarray-based classification of diffuse large B-cell lymphoma | Q38326709 | ||
| Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours | Q38437057 | ||
| High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses | Q38443265 | ||
| Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy | Q38477312 | ||
| Automated Analysis of Tissue Microarrays | Q39670492 | ||
| Development and use of a genitourinary pathology digital teaching set for trainee education | Q39842389 | ||
| Pre-conditioning cryosurgery: Cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model system | Q41992698 | ||
| Feature-based registration of histopathology images with different stains: an application for computerized follicular lymphoma prognosis | Q42134129 | ||
| Gene expression of ERbeta isoforms in laser microdissected human breast cancers: implications for gene expression analyses | Q54096883 | ||
| Prostatic carcinoma: histological and immunohistological factors affecting prognosis | Q68578366 | ||
| Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy | Q71218179 | ||
| Immunohistochemical Identification of Prostatic Acid Phosphatase: Correlation of Tumor Grade with Acid Phosphatase Distribution | Q72660124 | ||
| Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31 | Q73668134 | ||
| Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer | Q74299719 | ||
| Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma | Q76312993 | ||
| Microvessel density in prostate carcinoma | Q78704142 | ||
| Intratumoral heterogeneity of HER2/neu in breast cancer--a rare event | Q79825280 | ||
| Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors | Q81610968 | ||
| Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines | Q83722585 | ||
| Use of tumor necrosis factor-alpha-coated gold nanoparticles to enhance radiofrequency ablation in a translational model of renal tumors | Q84186100 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunohistochemistry | Q899285 |
| P304 | page(s) | e33520 | |
| P577 | publication date | 2012-01-01 | |
| 2012-03-15 | |||
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slides | |
| Development of Multigene Expression Signature Maps at the Protein Level from Digitized Immunohistochemistry Slides | |||
| P478 | volume | 7 |
| Q34429149 | A simplified approach for the molecular classification of glioblastomas |
| Q41698566 | Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma |
| Q35772123 | Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers |
| Q40116263 | Effects of Topical Copper Tripeptide Complex on Wound Healing in an Irradiated Rat Model |
| Q21261257 | Evaluation of protein biomarkers of prostate cancer aggressiveness |
| Q37595248 | Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity |
| Q30814598 | Intratumor mapping of intracellular water lifetime: metabolic images of breast cancer? |
| Q38212502 | Proteomic analysis of tissue samples in translational breast cancer research. |
| Q36048767 | Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring |
| Q48018514 | Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy |
| Q30394840 | Registration of whole immunohistochemical slide images: an efficient way to characterize biomarker colocalization |
| Q64066261 | Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens |
| Q36377976 | Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform |
Search more.